Researchers at Columbia University and CHOP believe they can shorten time to diagnosis and improve yield by extracting phenotypic data from EHRs for genomic labs.

In 2017, Bionano had $9.5 million in revenues and a net loss of 23.4 million, or $7.66 per share.

A ClinGen panel reports that only one gene linked to Brugada syndrome out of 21 tested has enough evidence supporting its inclusion in clinical genetic tests.

This week's news includes Thermo Fischer Scientific, Agilent Technologies, MiRxes, Becton Dickinson, Heart to Heart International National Assoc of Free & Charitable Clinics, MyHeritage, U of Alabama Birmingham, Cibus, and T2 Biosystems.

Collaborators said that the test is accurate and reliable for the rapid detection of the most common gram-positive bacteria responsible for bloodstream infections.

The partners have been working together since 2013 to use cancer and cardiovascular genomics for drug discovery.

Sociologists report that people select what aspects of their genetic ancestry test results they incorporate into their sense of ethnic or racial identity.

A US senator has sent letters to two biotech and pharmaceutical industry groups to ask about their approaches to handling sexual harassment, according to Stat News.

Wired reports on a set of mice being sent to space to study their gut microbiomes and sleep cycles as part of preparations for longer space travel.

In Science this week: gene expression patterns associated with severe cases of malaria, and more.

Using exome sequences from individuals with developmental delays, heart defects, and limb abnormalities, investigators identified four TRAF7 mutations.

Through the deal, Precision Therapeutics will acquire the 75 percent stake in Helomics that it does not already own.

It is the first of three ePlex molecular multiplex panels for the diagnosis and management of bloodstream infections that can lead to sepsis.

Patients whose tumors had methylated MGMT promoters were more likely to survive than those that did not after combination treatment with radiotherapy and temozolomide.

The project will investigate the use of whole-genome sequencing within the California Medical Assistance program.

Results support the ability of the test to not only identify hormonal therapy non-responders, but to predict their improved survival on chemotherapy.

A new analysis of immune cells in breast carcinomas and matched blood, breast, and lymph tissue uncovered phenotypic expansions in tumor immune cell populations.

The company plans to use the new funding to grow its suite of genomics applications to more than 50 in 2018.

The funding will help support the whole-genome and RNA sequencing of Alzheimer's disease patients to advance biomarker development.

The Intelligence Advanced Research Projects Activity has amassed a team to spot DNA orders that could be used in bioweapons, Bloomberg reports.

Researchers want to figure out why some cancer patients do so much better than expected, according to NPR's Shots blog.

A pair of researchers has found that retracted papers are often still cited and call for them to be harder to access, Retraction Watch reports.

In Nature this week: genetic loci linked to intelligence and neuroticism, and more.